Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
- Ames Test (OECD 471, K, rel. 2): non mutagenic up to 5000 μg/plate in S. typhimurium TA 1535, TA 1537, TA 98, TA 100
- HL/CAT chromosome aberration test (OECD 473, GLP, K, rel. 1): non clastogenic up to cytotoxic concentrations.
- MLA In Vitro Mammalian Cell Gene Mutation Test (OECD 476, GLP, K, rel. 1): non mutagenic up to cytotoxic concentrations
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1987
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- OECD guideline compliant as at 1987
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- as at 1987
- Deviations:
- yes
- Remarks:
- only 4 strains tested (E. Coli not tested), only plate incorporation assay used.
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- TA1535: his G46 rfa- delta uvrB-
TA1537: his C3076 rfa- delta uvrB-
TA98: his D3052 rfa- delta uvrB- R+
TA100: his G46 rfa- delta uvrB- R+ - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced rat liver S9
- Test concentrations with justification for top dose:
- Plate incorporation assay up to 10,000 µg Fe/plate + and - S9. Pre-incubation assay
- Vehicle / solvent:
- Vehicle used: distilled water
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- distilled water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- Remarks:
- without metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- distilled water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene for all strains
- Remarks:
- with metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation);
DURATION
- Exposure duration: 48 hours
- Expression time (cells in growth medium): 48 hours concurrent with exposure
SELECTION AGENT (mutation assays): minimal agar
NUMBER OF REPLICATIONS: doses were tested in triplicate in the plate incorporation assay . 5 dose levels were tested.
DETERMINATION OF CYTOTOXICITY
- Method:
• one Salmonella strain (TA98), based on the assumption that all strains used show a similar toxic response with and wo activation.
• concentrations: 0, 1.6, 8, 40, 200, 1000 and 5000 µg/plate.
• analysis of appearance of a complete bacterial lawn as seen under a dissecting microscope after 24 hours incubation at 37°C. - Evaluation criteria:
- A statistically significant increase in the mean number of revertants that exceeds twice the concurrent negative control, plus evidence of a dose response relationship.
- Statistics:
- • analysis of variance on each set of data to obtain the F-statistic
• in case of statistical significance (p<0.05) and dose related increases correlation coefficient is calculated for the response range and the significance of the result is determined from standard tables. - Species / strain:
- E. coli WP2 uvr A pKM 101
- Remarks:
- E. coli WP2 uvrA, not used in this study
- Metabolic activation:
- not applicable
- Genotoxicity:
- not determined
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- not applicable
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Remarks:
- AMINOL A15 LA 438-7 (FB-4136)
- Positive controls validity:
- not applicable
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: at 5000 µg/plate with and without activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: at 5000 µg/plate with and without activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: at 5000 µg/plate with and without activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: at 5000 µg/plate with and without activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Conclusions:
- Under the test conditions, test substance is not mutagenic with and without metabolic activation in Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100, up to 5000 µg/plate.
- Executive summary:
The test item was tested in vitro by the Ames plate incorporation method for its ability to induce mutations in four histidine dependent auxotrophic mutants of Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100 according to OECD 471 as at 1987.
Two independent mutation tests were performed, each in both the presence and absence of a metabolic activation system (S-9 mix) derived from the livers of Aroclor 1254 treated rats. The bacteria were exposed to the test material dissolved in Dimethylsulphoxide, which was also the solvent control. Based on the results of a preliminary toxicity rangefinder, 5000 µg/plate of AA 15 was chosen as the highest dose level to be used, with lower dose levels of 1000, 200, 40 and 8 µg/plate.
All solvent (negative) controls gave counts of revertants within normal ranges.
All positive controls gave numbers of induced revertants within expected ranges demonstrating the sensitivity of the assay and the metabolising activity of the S-9 mix.
The test item produced no significant increases in the number of revertants, with any of the tester strains, in either of the two experiments performed in both the presence and absence of metabolic activation, when assayed up to 5000 µg/plate.
Under the test conditions, test substance is not mutagenic in Salmonella typhimurium strains with and without metabolic activation, up to 5000 µg/plate.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23/12/1999-14/08/2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- According to the OECD Guideline and in compliance with GLP.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EC Guidelines: Methods for the Determination of Toxicity. Other Effects-Mutagenicuty (in vitro mammalian cytogenetic test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: CPMP/ICH/174/95 Note for Guidance on Genotoxicity: A standard Battery for Genotoxicity Testing of Pharmaceuticals
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
- Target gene:
- Not applicable
- Species / strain / cell type:
- lymphocytes: human
- Details on mammalian cell type (if applicable):
- CELLS USED
Human peripheral blood was obtained by venipuncture from healthy donors known to be without any medication and collected in heparinised vessels. Small inocula of whole blood (0.5mL) were added to tubes containing 5 mL of complete culture medium. The tubes were sealed and incubated at 37°C with occasional shaking to prevent clumping.
MEDIA USED
- Complete medium:
500 mL chromosome medium 1A with phytohemagglutinin (Gibco)
5 mL penicillin/streptomycin (10000 IU/mL)
- Treatment medium:
500 mL Ham's F-10
13.1 mL Fetal Calf Serum - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- The preparation of the Aroclor 1254 induced rat S9 fraction was carried out according to MARON & AMES and stored in liquid nitrogen util used. The SA was collected from 20 - 30 rats.
- Test concentrations with justification for top dose:
- The concentrations employed were chosen based on the result of a cytotoxicity study. In this preliminary experiment, without (24-hour exposure) and with metabolic activation (4-hour exposure), a nearly complete cytotoxicity was noted at a concentration of 1000 µg/mL medium whereas a complete cytotoxicity was observed starting from a concentration of 2500 µg/mL medium onwards.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium; in agar (plate incorporation); preincubation; in suspension; as impregnation on paper disk
DURATION
- Preincubation period: 4 hours
- Exposure duration:
- Expression time (cells in growth medium):
- Selection time (if incubation with a selection agent):
- Fixation time (start of exposure up to fixation or harvest of cells):
SELECTION AGENT (mutation assays):
SPINDLE INHIBITOR (cytogenetic assays):
STAIN (for cytogenetic assays):
NUMBER OF REPLICATIONS: duplicate cultures were used per sampling point employing blood from two different donors.
NUMBER OF CELLS EVALUATED:
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; cloning efficiency; relative total growth; other:
OTHER EXAMINATIONS:
- Determination of polyploidy:
- Determination of endoreplication:
- Other:
OTHER: - Statistics:
- The assessment was carried out by a comparison of the number of chromosome aberrations of the samples with those of the solvent control, using the exact test of R.A. FISHER (p ≤ 0.05) as recommended by the UKEMS guidelines.
- Key result
- Species / strain:
- lymphocytes: human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- Under the present test conditions, the substance tested up to cytotoxic concentrations in the absence and presence of metabolic activation is not clastogenic and not aneugenic in human lymphocytes.
- Executive summary:
Test samples of the substance were assayed in an in vitro cytogenetic study, using human lymphocyte cultures, both in the presence and absence of metabolic activation by a rat liver post-mitochonrial fraction (S9 mix) from Aroclor-1254 induced animals. DMSO served as the vehicle. The concentrations employed were chosen on the results of a cytotoxicity study. In this preliminary experiment, without (24 -hours exposure) and with metabolic activation (4 -hour exposure), a nearly complete cytotoxicity was noted at a concentration of 1000µg/ml medium whereas a complete cytotoxicity was observed starting from a concentration of 2500µg/ml medium onwards.Hence, the top concentration employed in this study was 250µg/mL using a 4 -hours and a 24 -hour exposure without metabolic activation. For the 4 -hour exposure (with metabolic activation), the top concentration employed was also 250µg/mL. Treatment with the concentrations of 62.5, 125 or 250µg/mL medium resulted in pronounced cytotoxicity in the experiment without metabolic activation (250µg/mL: 4 -h exposure; 62.5µg/mL: 24 -h exposure). Treatment with the concnetration of 125 or 250µg/mL resulted in moderate to severe cytotoxicity in the experiment with metabolic activation (4 -h exposure). The test was carried out employing 2 exposure times without S9: 4 and 24 hours, and 1 exposure time with S9:4 hours. The harvesting time was 24 hours after start of exposure. The incubation procedure took place in the dark. The study was conducted in duplicate. Mitomycin C and cyclophosphamide were employed as positive control chemicals in the absence and presence of metabolic activation, respectively. Test without metabolic activation (4 -and 24 -hour exposure): The mean incidence of chromosomal aberrations (excluding gaps) of the cells treated with the substance (15.625, 31.25, 62.5, 125 or 250 µg/mL medium) in the absence of metabolic activation ranged from 1.0% to 4.1% in the two independent experiments with blood from different donors. Severe cytotoxicity was noted at the concentration of 250µg/mL (mitotic index: 0.23and 0.13, respectively). The result are considered to be within the nominal range of the negative control where a mean incidence of chromosomal aberrations (excluding gaps) of 0.0% or 1.5% was observed after a 4 -hour or 24 -hour exposure.
Test with metabolic activation (4 -hour exposure): The mean incidence of chromosomal aberrations (excluding gaps) of the cells treated with the substance (15.625, 31.25, 62.5, 125 or 250µg/mL medium), in the presence of metabolic activation, ranged from 1.5% to 2.5% in the two independent experiments. Only at the severely cytotoxic concentration of 250µg/mL (mitotic index: 0.07) during the 4-hour exposure, a slight increase was noted in the number of aberrations to 5.2%. It is known that high cytotoxicity causes artefacts in the form of aberrations in "in vitro" chromosomal tests. Hence, the increase at the concentration of 250µg/mL is considered as artefact and not substance-related.
The results are considered to be within the nominal range of the negative control where a mean incidence of chromosomal aberrations (excluding gaps) of 0.5% was observed. The incidence of chromosomal aberrations (excluding gaps) of the controls was for the last 30 experiments 0.0%-5.0%.
Under the present test conditions, the substance tested up to cytotoxic concentrations in the absence and presence of metabolic activation, employing two exposure times (without S9) and one exposure time (with S9), revealed no indications of mutagenic properties with respect to chromosomal or chromatid damage in human lymphocytes.
In the same test, mitomycin C and cyclophosphamide induced significant damage.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 06/10/2008-22/12/2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- According to the OECD Guideline and in compliance with GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Principles of method if other than guideline:
- experiment I: 4 hours treatment with and without metabolic activation
experiment II: 24 hours treatment without metabolic activation and 4 hours treatment with metabolic activation
experiment IIA (repeat experiment): 24 hours treatment without metabolic activation - GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Specific details on test material used for the study:
- On the day of the experiment (immediately before treatment), the test item was dissolved in acetone (E. MERCK, 64293 Darmstadt; Germany, purity 99.5 %). The final concentration of acetone in the culture medium was 0.5 % (v/v).
- Target gene:
- Thymidine Kinase (TK) locus of heterozygous L5178Y/TK +/- cells to TK-/- mutants
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: RPMI
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: yes - Additional strain / cell type characteristics:
- other: Clone 3.7.2C
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver S9
- Test concentrations with justification for top dose:
- Experiment I:
without S9 mix: 0.9; 1.9; 3.8; 7.5; 15.0; 30.0 µg/mL (4 hours treatment)
with S9 mix: 1.9; 3.8; 7.5; 15.0; 30.0; 60.0 µg/mL (4 hours treatment)
Experiment II:
without S9 mix: 1.3; 2.5; 5.0, 10.0; 20.0; 30.0 µ/mL (24 hours treatment)
with S9 mix: 5.0; 10.0; 20.0; 40.0; 60.0; 80.0 µg/mL (4 hours treatment)
Experiment IIA:
without S9 mix: 20.0; 30.0; 40.0; 50.0; 60.0 µg/mL (24 hours treatment) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
- Justification for choice of solvent/vehicle: solubility properties - Negative solvent / vehicle controls:
- yes
- Remarks:
- acetone
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- methylmethanesulfonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: dissolved in medium
DURATION
- Exposure duration:
experiment I: 4 hours with and without metabolic activation in experiment 1;
experiment II: 24 hours without metaoblic activation and 4 hours treatment with metabolic activation;
experiment IIA: 24 hours treatment without metabolic activation
- Expression time (cells in growth medium): 48 hours
- Selection time (if incubation with a selection agent): 10 to 15 days
SELECTION AGENT (mutation assays): RPMI 1640 medium by addition of 5 µg/mL TFT
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: >1,5 x 10 exp. 6 cells
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
- Evaluation criteria:
- A test item is classified as mutagenic if the induced mutation frequency reproducibly exceeds a threshold of 126 colonies per 10 exp. 6 cells above the
corresponding solvent control or negative control, respectively.
A relevant increase of the mutation frequency should be dose-dependent.
A mutagenic response is considered to be reproducible if it occurs in both parallel cultures.
However, in the evaluation of the test results the historical variability of the mutation rates in negative
and/or vehicle con¬trols and the mutation rates of all negative and/or vehicle controls of this study are taken into consideration.
Results of test groups are generally rejected if the relative total growth, and the cloning efficiency 1 is less than 10 % of the vehicle control
unless the exception criteria specified by the IWGT recommendations are fulfilled.
Whenever a test item is considered mutagenic according to the above mentioned criteria, the ratio of small versus large colonies is used
to differentiate point mutations from clastogenic effects. If the increase of the mutation frequency is accompanied by a reproducible and
dose dependent shift in the ratio of small versus large colonies clastogenic effects are indicated. - Statistics:
- Linear regression analysis (least squares) using SYSTAT11 (SYSTAT Software, Inc., 501, Canal Boulevard, Suite C, Richmond, CA 94804, USA)
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- precipitation occurred in experiment I at 30 µg/mL without metabolic activation
- Conclusions:
- In conclusion it can be stated that during the mutagenicity test described and under the experimental conditions reported the test item did not induce mutations in the mouse lymphoma thymidine kinase locus assay using the cell line L5178Y in the absence and presence of metabolic activation.
Therefore, the test item is considered to be non-mutagenic in this mouse lymphoma assay at the TK locus. - Executive summary:
An in vitro mammalian cell gene mutation test was performed according to the OECD test guideline 476 and in compliance with GLP to investigate the potential of the test substance to induce mutations at the mouse lymphoma thymidine kinase locus using the cell line L5178Y.
The assay was performed in three independent experiments, using two parallel cultures each. The first main experiment was performed with and without liver microsomal activation and a treatment period of 4 h. The second experiment was performed with a treatment period of 24 hours in the absence of metabolic activation and 4 hours in the presence of metabolic activation.
In experiment I and II without metabolic activation the required toxicity range of approximately 10-20 % was not reached. Therefore, a repeat experiment was performed (experiment IIA) using modified concentrations. In experiment IIA the treatment period was 24 hours without metabolic activation.
The highest applied concentration in the pre-experiment (4000 µg/mL) was chosen with regard to the molecular weight of the test item corresponding to a molar concentration of about 10 mM. The concentration range of the main experiments was limited by cytotoxic effects.
The following dose levels were selected in the main experiments:
Experiment I:
without S9 mix: 0.9; 1.9; 3.8; 7.5; 15.0; 30.0 µg/mL (4 hours treatment)
with S9 mix: 1.9; 3.8; 7.5; 15.0; 30.0; 60.0 µg/mL (4 hours treatment)
Experiment II:
without S9 mix: 1.3; 2.5; 5.0, 10.0; 20.0; 30.0 µ/mL (24 hours treatment)
with S9 mix: 5.0; 10.0; 20.0; 40.0; 60.0; 80.0 µg/mL (4 hours treatment)
Experiment IIA:
without S9 mix: 20.0; 30.0; 40.0; 50.0; 60.0 µg/mL (24 hours treatment)
No substantial and reproducible dose dependent increase in mutant colony numbers was observed in both main experiments. No relevant shift of the ratio of small versus large colonies was observed up to the maximal concentration of the test item.
Appropriate reference mutagens were used as positive controls and showed a distinct increase in induced mutant colonies, indicating that the tests were sensitive and valid.
In conclusion it can be stated that during the mutagenicity test described and under the experimental conditions reported the test item did not induce mutations in the mouse lymphoma thymidine kinase locus assay using the cell line L5178Y in the absence and presence of metabolic activation.
Therefore, the test item is considered to be non-mutagenic in this mouse lymphoma assay at the TK locus.
Referenceopen allclose all
GENOTOXIC EFFECTS:
- The test item caused restricted growth of the background lawns for all four strains, both with and without S-9, at 5000 µg/plate.
- No dose related increases in revertant rates were seen with any of the strains except for TA1537 and TA98 without activation at the highest dose. The effects occur only at the highest dose and are deemed rather survivors of the cytotoxic effect than mutants. In addition the effects are neither dose related nor reproducible in experiment 2 and therefore not regarded as a positive mutagenic response.
- High concentrations of the test item caused decreases in numbers of revertants (except for the two concentrations nentioned above).
- All solvent (negative) controls gave counts of revertants within normal ranges
- All positive controls gave numbers of induced revertants within expected ranges demonstrating the sensitivity of the assay and the metabolising activity of the S-9 mix.
PRECIPITATION CONCENTRATION: None reported
Table 1: Pretest
Strain |
% |
Concentration of Test Substance (µg/plate)* |
||||||
0 |
1.6 |
8 |
40 |
200 |
1000 |
5000 |
||
TA98 |
0 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
TA98 |
10 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
* These are actual amounts of test substance added and correspond to solutions of test compound with concentrations from 16 µg/ml to 50 mg/ml.
+ = restricted growth
+ = normal growth
Table 2: MEAN NUMBER OF REVERTANTS PER PLATE FOR THE TEST ITEM
Strain |
% |
Concentration of Test Substance (µg/plate) |
||||||
0 |
8 |
40 |
200 |
1000 |
5000 |
PC |
||
TA1535 |
0 |
9.0 |
13.0 |
9.0 |
6.7 |
6.0 |
1.7 |
322.3 |
TA1537 |
0 |
3.0 |
5.0 |
3.7 |
4.0 |
1.7 |
1.7 |
1013.0 |
TA98 |
0 |
10.7 |
11.7 |
5.3 |
5.3 |
4.7 |
3.7 |
173.3 |
TA100 |
0 |
93.0 |
88.3 |
80.7 |
77.0 |
72.0 |
57.3 |
287.3 |
TA1535 |
10 |
11.0 |
12.3 |
7.7 |
10.7 |
7.0 |
4.7 |
95.7 |
TA1537 |
10 |
5.7 |
3.3 |
6.0 |
5.0 |
3.3 |
3.3 |
35.7 |
TA98 |
10 |
16.0 |
13.7 |
11.3 |
9,7 |
11.0 |
9.0 |
523.0 |
TA100 |
10 |
92.0 |
86.0 |
89.7 |
80.3 |
72.7 |
72.0 |
639.7 |
PC = Positive control
Table3: MEAN NUMBER OF REVERTANTS PER PLATE FOR THE TEST ITEM
Strain |
% |
Concentration of test substance (µg/plate) |
|
|||||
0 |
8 |
40 |
200 |
1000 |
5000 |
PC |
||
TA1535 |
0 |
5.3 |
8.3 |
4.7 |
6.3 |
4.7 |
1.7(a) |
262.3 |
TA1537 |
0 |
6.3 |
7.0 |
5.7 |
5.3 |
2.7 |
58.3(a) |
925.7 |
TA98 |
0 |
10.0 |
13.7 |
10.0 |
9.0 |
9.0 |
25.0(a) |
138.0 |
TA100 |
0 |
112.0 |
106.7 |
81.3 |
84.0 |
67.3 |
58.0(a) |
218.3 |
TA1535 |
10 |
10.0 |
9.7 |
8.7 |
6.7 |
4.3 |
3.7(a) |
186.7 |
TA1537 |
10 |
6.7 |
4.3 |
4.3 |
4.3 |
2.3 |
3.3(a) |
34.0 |
TA98 |
10 |
13.0 |
8.7 |
14.7 |
10.3 |
4.3 |
5.3(a) |
138.3 |
TA100 |
10 |
104.0 |
94.7 |
81.7 |
89.7 |
72.7 |
67.7(a) |
369.3 |
PC = Positive control
a = Reduced background lawn
Summary Table
conc. µg | S9 | total | colonies/ | total | colonies/ | |||
per mL | mix | growth | 106 cells | threshold | growth | 106 cells | threshold | |
Column | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
Experiment I / 4 h treatment | culture I | culture II | ||||||
Solv. control with acetone | - | 100.0 | 110 | 236 | 100.0 | 187 | 313 | |
Pos. control with MMS | 19.5 | - | 10.2 | 1059 | 236 | 34.8 | 378 | 313 |
Test item | 0.9 | - | 106.2 | 167 | 236 | 100.4 | 171 | 313 |
Test item | 1.9 | - | 78.4 | 231 | 236 | 80.3 | 274 | 313 |
Test item | 3.8 | - | 127.4 | 120 | 236 | 130.9 | 190 | 313 |
Test item | 7.5 | - | 57.6 | 292 | 236 | 124.1 | 155 | 313 |
Test item | 15.0 | - | 46.6 | 210 | 236 | 81.8 | 140 | 313 |
Test item | 30.0 (p) | - | culture was not continued# | culture was not continued# | ||||
Solv. control with acetone | + | 100.0 | 107 | 233 | 100.0 | 113 | 239 | |
Pos. control with CPA | 3.0 | + | 44.7 | 190 | 233 | 42.4 | 242 | 239 |
Pos. control with CPA | 4.5 | + | 22.6 | 335 | 233 | 15.0 | 304 | 239 |
Test item | 1.9 | + | culture was not continued## | culture was not continued## | ||||
Test item | 3.8 | + | 100.9 | 85 | 233 | 107.7 | 103 | 239 |
Test item | 7.5 | + | 92.8 | 91 | 233 | 95.3 | 90 | 239 |
Test item | 15.0 | + | 83.4 | 90 | 233 | 80.8 | 145 | 239 |
Test item | 30.0 | + | 98.1 | 68 | 233 | 75.3 | 93 | 239 |
Test item | 60.0 | + | 5.0 | 177 | 233 | 63.5 | 98 | 239 |
Experiment II / 24 h treatment | culture I | culture II | ||||||
Solv. control with acetone | - | 100.0 | 149 | 275 | 100.0 | 130 | 256 | |
Pos. control with MMS | 13.0 | - | 64.5 | 352 | 275 | 15.6 | 822 | 256 |
Test item | 1.3 | - | culture was not continued## | culture was not continued## | ||||
Test item | 2.5 | - | 173.9 | 107 | 275 | 99.6 | 135 | 256 |
Test item | 5.0 | - | 154.6 | 147 | 275 | 60.8 | 265 | 256 |
Test item | 10.0 | - | 97.4 | 186 | 275 | 66.1 | 224 | 256 |
Test item | 20.0 | - | 123.5 | 157 | 275 | 66.8 | 156 | 256 |
Test item | 30.0 | - | 65.2 | 202 | 275 | 69.0 | 115 | 256 |
Experiment II / 4 h treatment | culture I | culture II | ||||||
Solv. control with acetone | + | 100.0 | 95 | 221 | 100.0 | 130 | 256 | |
Pos. control with CPA | 3.0 | + | 39.6 | 256 | 221 | 38.0 | 241 | 256 |
Pos. control with CPA | 4.5 | + | 7.9 | 869 | 221 | 16.8 | 485 | 256 |
Test item | 5.0 | + | 81.8 | 106 | 221 | culture was not continued## | ||
Test item | 10.0 | + | 71.8 | 124 | 221 | 96.7 | 193 | 256 |
Test item | 20.0 | + | 82.5 | 131 | 221 | 76.8 | 212 | 256 |
Test item | 40.0 | + | 88.3 | 89 | 221 | 81.7 | 213 | 256 |
Test item | 60.0 | + | 52.8 | 118 | 221 | 61.3 | 230 | 256 |
Test item | 80.0 | + | culture was not continued# | 6.1 | 214 | 256 | ||
Experiment IIA / 24 h treatment | culture I | culture II | ||||||
Solv. control with acetone | - | 100.0 | 106 | 232 | 100.0 | 128 | 254 | |
Pos. control with MMS | 13.0 | - | 5.3 | 688 | 232 | 1.5 | 804 | 254 |
Test item | 20.0 | - | 26.5 | 162 | 232 | 36.2 | 230 | 254 |
Test item | 30.0 | - | 10.2 | 216 | 232 | 13.8 | 271 | 254 |
Test item | 40.0 | - | 3.2 | 142 | 232 | 4.6 | 205 | 254 |
Test item | 50.0 | - | culture was not continued# | culture was not continued# | ||||
Test item | 60.0 | - | culture was not continued# | culture was not continued# |
Threshold = number of mutant colonies per 10^6 cells of each solvent control plus 126
# culture not continued due to exceedingly strong toxic effects
## culture was not continued since a minimum of four concentrartions is required by the guidelines
p precipitation was observed in culture I
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Table 7.6/1: Summary of genotoxicity tests
Test n° |
Test / Guideline Reliability |
Focus |
Strains tested |
Metabolic activation |
Test concentration |
Statement |
1 |
Ames Test (OECD 471) K, rel. 2 |
Gene mutation |
TA 1535, TA 1537, TA 98, TA 100 |
-S9 +S9 |
Up to limit concentration |
-S9 : non mutagenic +S9 : non mutagenic |
2 |
HL/CAT (OECD 473) K, rel. 1 |
chromosome aberration |
Human Lymphocytes |
-S9 +S9 |
Up to cytotoxic concentrations |
-S9 : non clastogenic +S9 : non clastogenic |
3 | MLA (OECD 476) K, rel.1 |
gene mutation | L5178Y | -S9 +S9 |
Up to cytotoxic concentrations
|
-S9 : non mutagenic +S9 : non mutagenic |
Gene mutation Assays (Tests n° 1 & 3):
A Bacterial Reverse mutation Assay (Ames test) was performed similarly to OECD guideline No. 471 with the substance (See Table 7.6/1). No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains under the test conditions, with any dose of the substance, either in the presence or absence of metabolic activation. The substance does not induce gene mutations in bacteria whereas all positive control chemicals (with and without metabolic activation) induced significant increase of colonies.The substance is therefore considered as non-mutagenic in S. typhimurium according to the Ames test.
A cell mutation assay at the thymidine kinase locus (TK +/-) in mouse lymphoma L5178Y cells was performed according to the OECD guideline No. 476. The assay was performed in three independent experiments, using two parallel cultures each. The first main experiment was performed with and without liver microsomal activation and a treatment period of 4 h. The second experiment was performed with a treatment period of 24 hours in the absence of metabolic activation and 4 hours in the presence of metabolic activation.
No substantial and reproducible dose dependent increase in mutant colony numbers was observed in both main experiments. No relevant shift of the ratio of small versus large colonies was observed up to the maximal concentration of the test item.
Appropriate reference mutagens were used as positive controls and showed a distinct increase in induced mutant colonies, indicating that the tests were sensitive and valid. Under the tes conditions, the substance is therefore considered as non-mutagenic in mouse lymphoma cells at the TK locus.
Chromosomal aberration (Test n°2)
The clastogenic potential of the substance was determined using an in vitro chromosome aberration test in human lymphocytes (OECD guideline No. 473), which measures the potential of a substance to increase the incidence of structural chromosome aberrations in cultured human lymphocytes.
None of the dose levels up to the cytotoxicity limit with the substance, either in the presence or absence of metabolic activation, induced significant toxicological increases in the frequency of cells with aberrations in either of three experiments. The substance does not induce structural aberrations in the chromosomes of human lymphocytes under activation and non-activation conditions, whereas both positive control chemicals (with and without metabolic activation) induced significant increases in the frequency of aberrant cells.The substance is therefore considered as negative for inducing chromosomal mutations in human lymphocyte cells under activation and non-activation conditions used in this assay.
Justification for classification or non-classification
Harmonized classification:
The substance has no harmonized classification for human health according to the Regulation (EC) No. 1272/2008.
Self classification:
Based on the available data, no additional classification is proposed regarding genetic toxicity according to the Annex VI of the Regulation (EC) No. 1272/2008 (CLP) and to the GHS.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.